Moderna Inc logo

Moderna Inc

XBUL:0QF (USA)  
лв 111.60 (0%) Jul 12
At Loss
P/B:
3.63
Market Cap:
лв 84.10B ($ 46.91B)
Enterprise V:
лв 70.93B ($ 39.57B)
Volume:
50.00
Avg Vol (2M):
33.00
Trade In:
Volume:
50.00
At Loss

Business Description

Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 6.89
Equity-to-Asset 0.77
Debt-to-Equity 0.1
Debt-to-EBITDA -0.3
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.06
Distress
Grey
Safe
Beneish M-Score -3.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.05
9-Day RSI 1.93
14-Day RSI 8.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.03
Quick Ratio 3.91
Cash Ratio 3.58
Days Inventory 44.4
Days Sales Outstanding 60.89
Days Payable 34.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.4
Shareholder Yield % 1

Financials (Next Earnings Date:2024-08-02 Est.)

XBUL:0QF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Moderna Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil лв) 9,114.383
EPS (TTM) (лв) -28.098
Beta 0
Volatility % 0
14-Day RSI 8.14
14-Day ATR (лв) 3.713107
20-Day SMA (лв) 143.514
12-1 Month Momentum % 0
52-Week Range (лв) 109.06 - 149.5
Shares Outstanding (Mil) 383.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Moderna Inc Filings

Filing Date Document Date Form
No Filing Data

Moderna Inc Stock Events

Financials Calendars
Event Date Price(лв)
No Event Data

Moderna Inc Frequently Asked Questions

What is Moderna Inc(XBUL:0QF)'s stock price today?
The current price of XBUL:0QF is лв111.60. The 52 week high of XBUL:0QF is лв149.50 and 52 week low is лв109.06.
When is next earnings date of Moderna Inc(XBUL:0QF)?
The next earnings date of Moderna Inc(XBUL:0QF) is 2024-08-02 Est..
Does Moderna Inc(XBUL:0QF) pay dividends? If so, how much?
Moderna Inc(XBUL:0QF) does not pay dividend.

Press Release

Subject Date
No Press Release